Keiju Aokage

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Hisashi Saji, Morihito Okada, Masahiro Tsuboi et al. · The Lancet · 2022 · 1.7K citations

Medicine, Oncology, Surgery +13

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments

Shogo Kumagai, Shohei Koyama, Kota Itahashi et al. · Cancer Cell · 2022 · 838 citations

Medicine, Immunology, Oncology +17

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Shogo Kumagai, Yosuke Togashi, Takahiro Kamada et al. · Nature Immunology · 2020 · 812 citations

Life Sciences, Immunology, Oncology +17

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial

Kenji Suzuki, Hisashi Saji, Keiju Aokage et al. · Journal of Thoracic and Cardiovascular Surgery · 2019 · 497 citations · Full text

Medicine, Clinical Sciences, Surgery +11

Predominant infiltration of macrophages and CD8⁺ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer

Osamu Kawai, Genichiro Ishii, Kaoru Kubota et al. · Cancer · 2008 · 386 citations · Full text

Medicine, Oncology, Pathology +17